AIP
BSTC

Ameritas Investment Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Ameritas Investment Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-496
Closed -$26K – 3125
2020
Q3 		$26K Hold
496
– – ﹤0.01% 2253
2020
Q2 		$30K Hold
496
– – ﹤0.01% 2147
2020
Q1 		$28K Hold
496
– – ﹤0.01% 1997
2019
Q4 		$28K Hold
496
– – ﹤0.01% 2249
2019
Q3 		$27K Hold
496
– – ﹤0.01% 2245
2019
Q2 		$30K Hold
496
– – ﹤0.01% 2212
2019
Q1 		$31K Hold
496
– – ﹤0.01% 2146
2018
Q4 		$30K Hold
496
– – ﹤0.01% 2103
2018
Q3 		$29K Hold
496
– – ﹤0.01% 2319
2018
Q2 		$22K Hold
496
– – ﹤0.01% 2470
2018
Q1 		$22K Hold
496
– – ﹤0.01% 2387
2017
Q4 		$21K Hold
496
– – ﹤0.01% 2421
2017
Q3 		$23K Hold
496
– – ﹤0.01% 2367
2017
Q2 		$25K Buy
496
+170
+52% +$8.9K ﹤0.01% 2344
2017
Q1 		$18K Buy
+326
New +$17.3K ﹤0.01% 2479

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ameritas Investment Partners's BSTC Position: Q4 2020 in Review

Ameritas Investment Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 496 shares — an estimated $26K sold.

Ameritas Investment Partners first reported a position in BSTC in Q1 2017 and held it in 15 quarters. The position peaked at $31K in Q1 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Ameritas Investment Partners reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 496 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $26K.
  • Ameritas Investment Partners first reported a position in BioSpecifics Technologies Corp. in Q1 2017 and held it in 15 quarters.
  • Ameritas Investment Partners's BioSpecifics Technologies Corp. position peaked at $31K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.